Post-Streptococcal Immune-Mediated Syndromes
Post-streptococcal immune-mediated syndromes are delayed autoimmune complications following Group A Streptococcus (GAS) infection, primarily including acute rheumatic fever, post-streptococcal glomerulonephritis, post-streptococcal reactive arthritis, and the controversial PANDAS syndrome. 1, 2
Acute Rheumatic Fever (ARF)
Clinical Presentation and Timing
- ARF develops 14-21 days after GAS pharyngitis with a symptom-free interval, presenting as a febrile illness with multiple system involvement 1, 2
- The arthritis is migratory, transient, involves large joints, and responds rapidly to aspirin within 3 days 1, 2
- Major manifestations include arthritis, carditis/valvulitis, Sydenham chorea, erythema marginatum, and subcutaneous nodules 1, 2
- Carditis can lead to permanent valvular heart disease, making this the most serious long-term complication 1, 3
Diagnosis
- Requires evidence of recent streptococcal infection (elevated ASO titer) plus either two major Jones criteria OR one major and two minor criteria 2
- Electrocardiography, chest radiography, ESR, and ASO titer are the most useful initial tests 2
- Echocardiography is recommended to identify subclinical carditis, which may not be clinically apparent 2
- Minor criteria include fever, arthralgia, elevated inflammatory markers (ESR, CRP), and prolonged PR interval 2
Management
- Treat any documented acute GAS pharyngitis with standard 10-day antibiotic regimens (penicillin V, amoxicillin, or benzathine penicillin G IM) 4
- NSAIDs provide rapid symptom relief for arthritis, typically within 3 days 2
- Avoid aspirin in children due to Reye syndrome risk 4
- Patients with confirmed ARF require continuous antimicrobial prophylaxis (secondary prophylaxis) to prevent recurrent attacks 1
Secondary Prophylaxis Duration
- ARF with carditis and residual valvular disease: 10 years or until age 40 (whichever is longer), sometimes lifelong 1
- ARF with carditis but no residual heart disease: 10 years or until age 21 (whichever is longer) 1
- ARF without carditis: 5 years or until age 21 (whichever is longer) 1
Post-Streptococcal Glomerulonephritis (PSGN)
Clinical Presentation and Timing
- PSGN is an immune-complex mediated glomerular inflammation occurring after GAS pharyngitis or skin infection (impetigo) 5, 6
- Presents with microscopic or gross hematuria, hypertension, edema, and acute kidney injury 6, 2
- Can range from asymptomatic microscopic hematuria to severe presentations with proteinuria and elevated creatinine 2
- Most commonly affects children aged 2-6 years during winter months 7
Diagnosis
- Urinalysis showing hematuria with RBC casts is characteristic 6, 2
- Elevated ASO titer confirms recent GAS infection 6, 7
- Low C3 complement with normal C4 is typical, distinguishing it from other glomerulonephritides 6
- Imaging studies assess complications like pulmonary congestion or chronic kidney disease 5
Management
- Treatment is primarily supportive, focusing on managing hypertension, edema, and fluid overload 5, 6
- Antibiotics should be given to eradicate any active GAS infection, though they do not alter the course of established PSGN 5
- Prognosis in children is excellent, even with severe initial renal impairment 6
- Monitor for progression to chronic kidney disease, though this is rare in children 5
Critical Pitfall
- PSGN and ARF can occur simultaneously in the same patient, as they result from different antigenic epitopes on GAS, requiring treatment for both conditions 3
Post-Streptococcal Reactive Arthritis (PSRA)
Clinical Presentation and Timing
- PSRA occurs approximately 10 days after GAS pharyngitis, earlier than ARF 1
- The arthritis is cumulative, persistent, non-migratory, and does NOT respond readily to aspirin 1
- Can involve large joints, small joints, or axial skeleton, unlike ARF which primarily affects large joints 1
Diagnosis
- All patients have serological evidence of recent GAS infection, though throat cultures may be negative in over half 1
- Distinguished from ARF by timing, aspirin response, and joint involvement pattern 1
Management and Monitoring
- Observe carefully for several months for clinical evidence of carditis, as some PSRA patients develop valvular heart disease 1
- Consider secondary prophylaxis for up to 1 year after symptom onset (Class IIb recommendation), though effectiveness is not well established 1
- If valvular disease develops, reclassify as ARF and continue secondary prophylaxis per ARF guidelines 1
- If no carditis develops after observation period, prophylaxis can be discontinued 1
Important Caveat
- It remains unclear whether PSRA represents a distinct syndrome or a manifestation of ARF, as the entity has been used inconsistently in literature 1
PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections)
Current Evidence Status
- The American Heart Association considers PANDAS "an unproven hypothesis" that requires careful consideration 1, 8, 4
- No causal relationship between GAS infections and these neuropsychiatric symptoms has been established by well-controlled studies 1, 4
- The concept was proposed in 1998, suggesting childhood OCD and/or tics may arise from post-streptococcal autoimmune processes similar to Sydenham chorea 1, 4
Clinical Features (If Considering This Diagnosis)
- Sudden onset of obsessive-compulsive symptoms and/or tics with temporal relationship to GAS infection 9
- Affects the basal ganglia through proposed autoimmune cross-reactivity with brain tissue 1, 2
- Distinguished from classic OCD by abrupt onset rather than gradual progression 8
What TO DO
- If a child presents with new-onset OCD or tics after strep throat, treat any documented acute streptococcal pharyngitis with standard 10-day antibiotic regimens (penicillin V, amoxicillin, or benzathine penicillin G IM) 4
- Refer to pediatric neurology and/or psychiatry for evaluation and management of neuropsychiatric symptoms with standard therapies for OCD/tic disorders 4
What NOT TO DO (Critical Pitfalls)
- DO NOT prescribe long-term prophylactic antibiotics for presumed PANDAS without documented recurrent streptococcal infections - this lacks evidence and promotes resistance 4
- DO NOT order extensive streptococcal testing (serial ASO titers, anti-DNase B) to diagnose or manage PANDAS - routine laboratory testing for GAS is not recommended 1, 8, 4
- DO NOT use immunoregulatory therapy (IVIG, plasma exchange) as routine treatment - this is not recommended (Class III recommendation) 1, 8
Laboratory Testing (If Pursued Despite Recommendations)
- ASO titer begins rising ~1 week after infection, peaks at 3-6 weeks 9
- Anti-DNase B titer begins rising 1-2 weeks after infection, peaks at 6-8 weeks, and may remain elevated longer than ASO 9
- Normal streptococcal antibody levels are higher in school-age children than adults, requiring age-specific reference ranges 9
- Positive results reflect past rather than present immunologic events and require careful clinical correlation 9
General Diagnostic Approach to Post-Streptococcal Syndromes
Evidence of Recent GAS Infection
- Obtain ASO titer first to detect recent GAS infection 9, 7
- If ASO is negative, obtain anti-DNase B titer, as it may remain elevated longer 9, 7
- Additional antibody markers include antihyaluronidase, antideoxyribonuclease B, and antistreptokinase 7
Inflammatory Markers
- Complete blood count, ESR, and CRP assess for systemic inflammation 2, 7
- These are particularly useful in ARF diagnosis and monitoring 2
Timing Considerations
- ARF: 14-21 days post-pharyngitis 1
- PSRA: ~10 days post-pharyngitis 1
- PSGN: Variable, typically 1-3 weeks post-pharyngitis or skin infection 5, 6
Chronic Carriers vs. Acute Infection
- Chronic GAS carriers have positive throat cultures without immunologic response (no rising antibody titers) 1
- Carriers are at very low risk for developing nonsuppurative complications like ARF 1
- A single course of appropriate antibiotic therapy should be administered to any patient with acute pharyngitis and positive GAS testing 1
- Routine post-treatment cultures are not recommended unless patients remain symptomatic 1